癫痫性与非癫痫性发作相关血浆蛋白变化
该研究在癫痫监测单元收集发作后24小时内血样,检测51种血浆蛋白,结合临床风险因素构建多模态算法区分癫痫性发作(ES)与心因性非癫痫性发作(PNES)。四蛋白组合(TRAIL、ICAM-1、MCP-2、TNF-R1)单独算法AUC 0.94±0.07,敏感性82.6%、特异性91.6%;加入PNES风险因素后AUC 0.97±0.05,敏感性91.3%、特异性95.8%。
要点
- 四蛋白(TRAIL、ICAM-1、MCP-2、TNF-R1)算法可区分近期ES与PNES,AUC 0.94。
- 加入临床PNES风险因素后诊断性能提升至AUC 0.97。
- PNES中TRAIL和ICAM-1较高,ES中MCP-2和TNF-R1较高。
核心结论
- 四种血浆蛋白联合诊断算法可快速、经济、准确地确认近期ES或PNES。
研究设计与样本
- 研究在癫痫监测单元收集脑电图确认ES或PNES后24小时内的每日血样,分离血浆。
- 使用自动化多重三明治ELISA定量51种候选血浆蛋白,并整合临床风险因素分析。
主要发现
- TRAIL和ICAM-1在PNES中高于ES,MCP-2和TNF-R1在ES中高于PNES。
- 四蛋白算法AUC为0.94±0.07,敏感性82.6%(95%CI 62.9-93.0),特异性91.6%(95%CI 74.2-97.7)。
- 加入PNES风险因素后AUC为0.97±0.05,敏感性91.3%(95%CI 73.2-97.6),特异性95.8%(95%CI 79.8-99.3)。
关键数值与推荐
- 四蛋白组合(TRAIL、ICAM-1、MCP-2、TNF-R1)指示近期发作概率。
- 研究提供Class III证据:四蛋白水平经算法分析区分PNES与ES的敏感性82.6%、特异性91.6%。
临床怎么用
- 该血基诊断算法有望辅助快速区分近期ES与PNES,减少诊断延迟。
- 结合临床PNES风险因素可进一步提高诊断准确性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop a diagnostic test that stratifies epileptic seizures (ES) from psychogenic nonepileptic seizures (PNES) by developing a multimodal algorithm that integrates plasma concentrations of selected immune response-associated proteins and patient clinical risk factors for seizure. METHODS: Daily blood samples were collected from patients evaluated in the epilepsy monitoring unit within 24 hours after EEG confirmed ES or PNES and plasma was isolated. Levels of 51 candidate plasma proteins were quantified using an automated, multiplexed, sandwich ELISA and then integrated and analyzed using our diagnostic algorithm. RESULTS: A 51-protein multiplexed ELISA panel was used to determine the plasma concentrations of patients with ES, patients with PNES, and healthy controls. A combination of protein concentrations, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), intercellular adhesion molecule 1 (ICAM-1), monocyte chemoattractant protein-2 (MCP-2), and tumor necrosis factor-receptor 1 (TNF-R1) indicated a probability that a patient recently experienced a seizure, with TRAIL and ICAM-1 levels higher in PNES than ES and MCP-2 and TNF-R1 levels higher in ES than PNES. The diagnostic algorithm yielded an area under the receiver operating characteristic curve (AUC) of 0.94 ± 0.07, sensitivity of 82.6% (95% confidence interval [CI] 62.9-93.0), and specificity of 91.6% (95% CI 74.2-97.7). Expanding the diagnostic algorithm to include previously identified PNES risk factors enhanced diagnostic performance, with AUC of 0.97 ± 0.05, sensitivity of 91.3% (95% CI 73.2-97.6), and specificity of 95.8% (95% CI 79.8-99.3). CONCLUSIONS: These 4 plasma proteins could provide a rapid, cost-effective, and accurate blood-based diagnostic test to confirm recent ES or PNES. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that variable levels of 4 plasma proteins, when analyzed by a diagnostic algorithm, can distinguish PNES from ES with sensitivity of 82.6% and specificity of 91.6%.
引用
- Gledhill JM, Brand EJ, Pollard JR, et al. Association of Epileptic and Nonepileptic Seizures and Changes in Circulating Plasma Proteins Linked to Neuroinflammation. Neurology. 2021. PMID: 33495377. doi:10.1212/WNL.0000000000011552
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。